Recombinant multi-species CCT4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CCT4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The chaperonin containing TCP1 (MIM 186980) complex (CCT), also called the TCP1 ring complex, consists of 2 back-to-back rings, each containing 8 unique but homologous subunits, such as CCT4. CCT assists the folding of newly translated polypeptide substrates through multiple rounds of ATP-driven release and rebinding of partially folded intermediate forms. Substrates of CCT include the cytoskeletal proteins actin (see MIM 102560) and tubulin (see MIM 191130), as well as alpha-transducin (MIM 139330) (Won et al., 1998 [PubMed 9819444]).[supplied by OMIM, Mar 2008]
The Alternative Names of target: CCT4,T-complex protein 1 subunit delta,TCP-1-delta,CCT-delta, Chaperonin containing T-complex polypeptide 1 subunit 4, Stimulator of TAR RNA-binding,SRB,Cctd,CCT-DELTA

Target products collectionGo to CCT4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0516-Ab-1/ GM-Tg-hg-IP0516-Ab-2 Human CCT4 protein Human
GM-Tg-rg-IP0516-Ab-1/ GM-Tg-rg-IP0516-Ab-2 Rat CCT4 protein Rat
GM-Tg-mg-IP0516-Ab-1/ GM-Tg-mg-IP0516-Ab-2 Mouse CCT4 protein Mouse
GM-Tg-cynog-IP0516-Ab-1/ GM-Tg-cynog-IP0516-Ab-2 Cynomolgus/Rhesus macaque CCT4 monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0516-Ab-1/ GM-Tg-felg-IP0516-Ab-2 Feline CCT4 protein Feline
GM-Tg-cang-IP0516-Ab-1/ GM-Tg-cang-IP0516-Ab-2 Canine CCT4 protein Canine
GM-Tg-bovg-IP0516-Ab-1/ GM-Tg-bovg-IP0516-Ab-2 Bovine CCT4 protein Bovine
GM-Tg-equg-IP0516-Ab-1/ GM-Tg-equg-IP0516-Ab-2 Equine CCT4 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0516-Ab-1/ GM-Tg-hg-IP0516-Ab-2; GM-Tg-rg-IP0516-Ab-1/ GM-Tg-rg-IP0516-Ab-2;
GM-Tg-mg-IP0516-Ab-1/ GM-Tg-mg-IP0516-Ab-2; GM-Tg-cynog-IP0516-Ab-1/ GM-Tg-cynog-IP0516-Ab-2;
GM-Tg-felg-IP0516-Ab-1/ GM-Tg-felg-IP0516-Ab-2; GM-Tg-cang-IP0516-Ab-1/ GM-Tg-cang-IP0516-Ab-2;
GM-Tg-bovg-IP0516-Ab-1/ GM-Tg-bovg-IP0516-Ab-2; GM-Tg-equg-IP0516-Ab-1/ GM-Tg-equg-IP0516-Ab-2
Products Name CCT4 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CCT4
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CCT4 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.